Align Technology Inc

Healthcare · Medical Instruments & Supplies

146.80$ +0.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Align Technology Inc (ALGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,056 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ALGN
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	279	293	310	356	385	421	437	490	505	534	549	601	607	650	551	352	734	835	895	1,011	1,016	1,031	973	970	890	902	943	1,002	960	957	997	1,028	978	995	979	1,012	996	1,048	1,040	1,056	4,140
Cost of Revenue	69	73	75	86	93	103	110	125	134	151	147	168	170	178	157	128	200	224	218	252	261	287	264	282	271	284	282	289	297	287	300	306	296	298	299	304	356	359	304	368	1,388
Gross Profit	209	220	236	271	292	318	327	366	372	383	402	432	438	472	394	224	534	610	677	759	755	745	709	688	619	618	661	714	663	670	698	723	682	697	680	708	639	688	737	688	2,752
Research & Development	20	22	23	24	24	26	30	31	33	36	38	39	40	41	42	40	45	49	55	58	66	72	72	73	77	84	87	88	89	82	92	92	85	95	97	96	93	83	99	102	377
Selling, General & Administrative	127	94	151	163	170	112	200	212	214	138	247	268	278	160	283	257	312	283	397	432	428	451	439	426	399	410	440	453	408	403	452	452	434	240	448	449	418	442	465	463	1,787
Total Operating Expenses	147	152	174	187	194	208	229	243	247	263	314	256	310	321	324	297	357	397	452	490	494	524	511	499	476	505	527	542	497	498	544	576	519	553	549	545	543	529	564	565	2,200
Operating Income	62	68	62	84	99	110	98	123	125	120	88	176	127	151	70	-73	177	213	225	269	261	221	198	188	144	113	134	172	166	172	154	147	162	144	131	163	96	160	173	123	552
Interest Expense	1.5	7.5	1.6	3.2	3.8	11	0.0	0.0	0.0	0.0	–	–	–	–	17	0.5	7.5	8.2	36	0.1	0.8	0.9	0.7	0.2	1.7	2.8	1.1	0.3	4.2	1.3	4.3	3.2	1.1	–	–	–	1.6	–	–	–	–
Pre-Tax Income	64	61	63	87	103	112	101	118	127	120	81	190	128	156	53	-73	185	215	262	269	262	220	187	174	123	115	135	172	162	173	158	144	166	141	140	174	95	177	149	149	569
Income Tax Expense	12	12	-7.2	15	18	104	2.9	7.7	25	23	8.8	43	26	35	-1,465	-33	45	56	61	69	81	29	53	61	50	74	47	60	41	49	53	47	50	37	47	49	38	41	36	40	155
Net Income	51	48	69	69	83	10	96	106	101	97	72	147	103	121	1,518	-41	139	159	200	200	181	191	134	113	73	42	88	112	121	124	105	97	116	104	93	125	57	136	113	108	414
EBITDA	69	76	70	92	109	121	110	135	139	137	136	145	140	173	91	-49	202	238	251	295	290	250	217	204	155	158	170	207	199	219	191	214	200	215	174	214	212	279	205	91	786

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings